Allplex™ MG & MoxiR Assay is a multiplex Real-time PCR assay that detects and identifies M. genitalium and 6 mutations in parC gene related moxifloxacin resistance. Based on Seegene’s proprietary MuDT™ Technology, this assay enables to check MG infection and moxifloxacin resistance in a single test and reports individual Ct values of each pathogen in a single channel without melting curve analysis.
Key Features and Benefits
-
Multiplex real-time PCR
Simultaneous detection and identification of MG and 6 mutations in parC gene related moxifloxacin resistance
-
Short TAT
Short TAT (3.5 hours) from extraction to the final results
-
User-friendly workflow
Convenient workflow using Seegene’s automated one platform
-
Automatic data analyzer
Automated data interpretation and LIS interlocking with Seegene Viewer
-
UDG system
Utilization of the UDG system to prevent carry-over contamination
-
Multi-Ct in a single channel
Individual Ct value of multiple analytes in a single channel of real-time PCR instrument (MuDT™ Technology)
-
Proper patient care
Quick and proper treatment provided by accurate test results
-
Proper patient care
Quick and proper treatment provided by accurate test results
-
Whole process validation
Whole process validation from extraction to PCR by whole process control
-
Prediction of antibiotic resistance
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
-
Analytes
Allplex™
MG & MoxiR Assay
- A247C
- G248A
- G248T
- G259A
- G259C
- G259T
- Mycoplasma genitalium (MG)
- Internal Control (IC)
-
Specimens
- Genital swab
- Urine
- Liquid based cytology (e.g., ThinPrep® and Surepath™)
-
Ordering Information
Result
Multiple Ct value in a single channel
The result represents detection of MG with A247C mutation in Quasar670 and FAM channel with Ct values of 26.52 (Graph 2) and 29.21 (Graph 1), respectively.
Note
[1] For use with Seegene NIMBUS & STARlet only